News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Three Top Life Sciences Brokers Join CBRE in Seattle
CBRE recently announced the addition of three new life sciences real estate specialists to its Seattle office: Chris Moe, Hans Kemp, and Austin Arper. Moe
With some space pre-leased, construction starts on Seattle life science tower
A new 11-story life sciences building is underway in Seattle’s Denny Triangle neighborhood. The 1916 Boren tower will include 282,700 square feet of space, of
Washington’s Life Science Industry Bolsters Slowing Economy
The life science industry tends to be a buffer when the economy slows; in fact, a recent analysis by the Puget Sound Business Journal indicates
The U.S. Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward
The Biotechnology Innovation Organization (BIO) has released the tenth annual biennial report showcasing employment and economic data of the nation’s biosciences industry. The report highlights
Seattle startup with fresh approach to Parkinson’s and Alzheimer’s disease raises $96M
Cajal Neuroscience, a Seattle-based startup, announced a $96 million funding round and released details on its strategy for developing treatments for neurodivergent diseases. The company
HDT Bio receives $49M to develop vaccines for deadly viruses
Seattle-based biotech HDT Corp. announced a $49 million funding round as part of a government project in partnership with the University of Texas Medical Branch
Seattle-area health startup One Item expands CDC-backed heart study
One Item, a Seattle-area startup, is continuing its partnership with the University of Arkansas for Medical Studies (UAMS), expanding a study of rural Arkansas communities
Seattle vaccine startup taking on pharma giant GSK with shingles shot raises $26M
Cuervo, a Seattle-based vaccine startup, raised $26 million in a funding round with participation from RA Capital Management, Adjuvant Capital, and founding investor GC Biopharma,
Advice for entrepreneurs in the medical device industry on raising cash and growing startups
At Life Science Washington’s 2022 Medical Device Summit investors, regulatory experts and CEOs shared their expertise and advice on breaking through as an entrepreneur in
Seattle biotech Bonum raises $93M Series A round
Seattle-based biotech Bonum Therapeutics recently announced a $93 million Series A funding round, with participation from Rivervest Venture Partners, Roche Venture Fund, Digitalis Ventures, 3×5
Sana and BioLife Tout BioForest Region as Best Place to Work
Two Washington-based biotechs have made BioSpace’s 2023 Best Places to Work report. Seattle-based Sana Biotechnology has been voted the best place to work in the
Without health care jobs and funding, US would have been in a deep recession
The healthcare and life sciences private and public sectors have helped prevent the U.S. from plummeting into a deep recession through commercialization and job creation.